Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled trial of anakinra in hidradenitis suppurativa (HIDRA03)
2011-005145-12Phase 2Completed
- Sponsor
- National and Kapodistrian University of Athens School of Medicine
- Start
- Nov 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in hidradenitis suppurativa (HS), sponsored by National and Kapodistrian University of Athens School of Medicine. Started Nov 2011; status: completed.
02
Drugs
anakinra
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2011-005145-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005145-12.